INVO Fertility Price to Book Ratio 2010-2024 | IVF
Historical price to book ratio values for INVO Fertility (IVF) over the last 10 years. The current price to book ratio for INVO Fertility as of May 09, 2025 is 0.00.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| INVO Fertility Price/Book Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | Book Value per Share | Price to Book Ratio |
| 2025-05-09 | 2.09 | 0.00 | |
| 2024-09-30 | 8.52 | $-0.07 | -118.83 |
| 2024-06-30 | 10.08 | $4.24 | 2.38 |
| 2024-03-31 | 13.56 | $0.05 | 290.99 |
| 2023-12-31 | 16.20 | $4.30 | 3.77 |
| 2023-09-30 | 9.48 | $1.81 | 5.24 |
| 2023-06-30 | 48.00 | $-24.76 | -1.94 |
| 2023-03-31 | 153.36 | $1.52 | 100.87 |
| 2022-12-31 | 101.76 | $-19.27 | -5.28 |
| 2022-09-30 | 254.40 | $25.40 | 10.01 |
| 2022-06-30 | 153.60 | $66.44 | 2.31 |
| 2022-03-31 | 633.60 | $110.95 | 5.71 |
| 2021-12-31 | 799.20 | $147.14 | 5.43 |
| 2021-09-30 | 782.40 | $54.06 | 14.47 |
| 2021-06-30 | 1116.00 | $100.05 | 11.15 |
| 2021-03-31 | 1039.20 | $128.95 | 8.06 |
| 2020-12-31 | 722.40 | $143.05 | 5.05 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $0.002B | $0.007B |
| INVO Fertility Inc. is a healthcare services fertility company focused on expanding access to advanced treatment through the establishment, acquisition and operation of fertility clinics. INVO Fertility Inc., formerly known as NAYA Biosciences Inc., is based in SARASOTA, Fla. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $135.784B | 25.47 |
| Elevance Health (ELV) | United States | $91.409B | 11.80 |
| CVS Health (CVS) | United States | $84.718B | 10.53 |
| Cencora (COR) | United States | $54.879B | 19.08 |
| DiDi Global (DIDIY) | China | $20.661B | 31.36 |
| Natera (NTRA) | United States | $20.542B | 0.00 |
| BioMerieux (BMXMF) | France | $15.263B | 0.00 |
| Solventum (SOLV) | United States | $12.150B | 12.86 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $11.973B | 0.00 |
| Doximity (DOCS) | United States | $11.050B | 57.47 |
| CochLear (CHEOY) | Australia | $10.944B | 0.00 |
| ICON (ICLR) | Ireland | $10.818B | 10.06 |
| Revvity (RVTY) | United States | $10.756B | 18.51 |
| Viatris (VTRS) | United States | $10.293B | 3.54 |
| Medpace Holdings (MEDP) | United States | $8.508B | 22.60 |
| Sonic Healthcare (SKHHY) | Australia | $8.280B | 0.00 |
| Avantor (AVTR) | United States | $8.191B | 11.90 |
| HealthEquity (HQY) | United States | $7.819B | 38.47 |
| Charles River Laboratories (CRL) | United States | $6.817B | 13.36 |
| Amplifon S.p.A (AMFPF) | Italy | $4.966B | 26.21 |
| Bausch + Lomb (BLCO) | Canada | $3.982B | 23.48 |
| BrightSpring Health Services (BTSG) | United States | $3.976B | 36.81 |
| Sotera Health (SHC) | United States | $3.727B | 21.18 |
| Alignment Healthcare (ALHC) | United States | $2.991B | 0.00 |
| Surgery Partners (SGRY) | United States | $2.841B | 32.59 |
| Concentras Parent (CON) | United States | $2.743B | 15.85 |
| Organon (OGN) | United States | $2.264B | 2.41 |
| Premier (PINC) | United States | $2.106B | 14.42 |
| Ardent Health Partners (ARDT) | United States | $2.077B | 8.85 |
| Progyny (PGNY) | United States | $1.815B | 39.98 |
| GeneDx Holdings (WGS) | United States | $1.687B | 64.99 |
| GoodRx Holdings (GDRX) | United States | $1.657B | 30.86 |
| PACS (PACS) | United States | $1.590B | 0.00 |
| Pediatrix Medical (MD) | United States | $1.248B | 9.50 |
| Teladoc Health (TDOC) | United States | $1.247B | 0.00 |
| Agilon Health (AGL) | United States | $1.196B | 0.00 |
| Ryman Healthcare (RYHTY) | New Zealand | $1.039B | 0.00 |
| Establishment Labs Holdings (ESTA) | $0.978B | 0.00 | |
| CareDx (CDNA) | United States | $0.855B | 13.36 |
| AMN Healthcare Services Inc (AMN) | United States | $0.840B | 7.89 |
| Embecta (EMBC) | United States | $0.696B | 4.71 |
| QDM (QDMI) | Hong Kong, SAR China | $0.690B | 0.00 |
| Nutex Health (NUTX) | United States | $0.667B | 13.08 |
| Enhabit (EHAB) | United States | $0.521B | 42.83 |
| Auna S.A (AUNA) | Luxembourg | $0.508B | 13.45 |
| InnovAge Holding (INNV) | United States | $0.491B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.466B | 0.00 |
| LifeMD (LFMD) | United States | $0.375B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.352B | 0.00 |
| SBC Medicals (SBC) | United States | $0.345B | 0.00 |
| Beauty Health (SKIN) | United States | $0.234B | 0.00 |
| Oncology Institute (TOI) | United States | $0.212B | 0.00 |
| Performant Healthcare (PHLT) | United States | $0.195B | 0.00 |
| DocGo (DCGO) | United States | $0.143B | 23.33 |
| Basel Medical Group (BMGL) | Singapore | $0.088B | 0.00 |
| So-Young (SY) | China | $0.086B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.084B | 0.00 |
| OncoCyte (OCX) | United States | $0.082B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.076B | 0.00 |
| NeueHealth (NEUE) | United States | $0.060B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.057B | 0.00 |
| Biodesix (BDSX) | United States | $0.054B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.029B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.029B | 0.00 |
| KindlyMD (KDLY) | United States | $0.023B | 0.00 |
| ModivCare (MODV) | United States | $0.017B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.012B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.011B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.008B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.005B | 0.00 | |
| XWELL (XWEL) | United States | $0.005B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.002B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |